Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

1.42
Delayed Data
As of 9:37am ET
 +0.0165 / +1.18%
Today’s Change
0.86
Today|||52-Week Range
2.19
+61.89%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close1.40
Today’s open1.42
Day’s range1.41 - 1.45
Volume220,241
Average volume (3 months)731,151
Market cap$77.7M
Dividend yield--
Data as of 9:37am ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)+9.09%
Earnings growth (this year)-7.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.12

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...-0.05-3.51%
EGLTEgalet Corp+0.09+3.21%
NNVCNanoViricides Inc+0.01+0.76%
NVETNexvet Biopharma plc0.000.00%
Data as of 9:48am ET, 05/24/2017

Financials

Next reporting dateJuly 31, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$24.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Medical Officer
Mark S. Berger
Vice President-Finance &
Business Development
Corey Sohmer
Corporate headquarters
New York, New York

Forecasts